Christopher Wolf

Mpm Bioimpact Llc

Assets Managed

$1.295B

Holdings

Last Quarter

2026 - Q1

Filed Date

11d ago

Growth Rate

48.17%(2Q avg: 45.62%)

Sustained Growth

3 quarters

Portfolio positions

This chart displays the top 10 holdings in Mpm Bioimpact Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 41 positions.

Assets under management

The assets under management (AUM) of Mpm Bioimpact Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 3 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 1.295B in assets, with a quarterly growth rate of 48.17% and a 2-quarter average growth rate of 45.62%. The portfolio is managed by Christopher Wolf, and others.

Portfolio holdings

Investment	Portfolio %	Reported Value	Recent Activity
DBVT Dbv Technologies Sa-spon Adr Recent Activity Increased 423%	8.42%	$108.907M 5.213M shares@ $20.89 avg price	Increased 423%
CGEM Cullinan Therapeutics Inc Recent Activity	8.4%	$108.682M 7.648M shares@ $14.21 avg price
AKTS Aktis Oncology Inc Recent Activity New Position	6.69%	$86.514M 4.836M shares@ $17.89 avg price	New Position
LQDA Liquidia Corp Recent Activity Increased 0.31%	4.1%	$53.031M 1.405M shares@ $37.75 avg price	Increased 0.31%
ALMS Alumis Inc Recent Activity Decreased -0.64%	4.07%	$52.575M 2.387M shares@ $22.04 avg price	Decreased -0.64%
EWTX Edgewise Therapeutics Inc Recent Activity Increased 0.33%	4.04%	$52.312M 1.661M shares@ $31.5 avg price	Increased 0.33%
RVMD Revolution Medicines Inc Recent Activity Increased 0.22%	3.81%	$49.284M 506,776 shares@ $97.25 avg price	Increased 0.22%
AGIO Agios Pharmaceuticals Inc Recent Activity Increased 0.23%	3.42%	$44.191M 1.306M shares@ $33.84 avg price	Increased 0.23%
CORT Corcept Therapeutics Inc Recent Activity New Position	3.07%	$39.734M 985,700 shares@ $40.31 avg price	New Position
TRVI Trevi Therapeutics Inc Recent Activity Increased 0.35%	3.04%	$39.35M 3.298M shares@ $11.94 avg price	Increased 0.35%

1-10 of 41